ADMA Biologics, Inc. (ADMA)
$10.36+0.29%Close
BUYRECOVERY · day 15
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2.4B
- Beta
- 0.77
- P/E (TTM)
- 14.14
- Short % float
- 9.09%
- Days to cover
- 5.7
- SI change
- -14.9%
- 1W
- +6.58%
- 1M
- +10.33%
- vs SPY 1W
- +5.42%
- vs SPY 1M
- +7.34%
Industry peers
FMP comparable companies · ranked by market cap
- CRNXBUYCrinetics Pharmaceuticals, Inc.$9.0BBULLQ 26$84.95+0.00%
- PRAXSELLPraxis Precision Medicines, Inc.$8.2BCRISISQ 11$295.51-1.40%
- BLTESELLBelite Bio, Inc$6.4BBEARQ 53$159.56+1.29%
- LGNDBUYLigand Pharmaceuticals Incorporated$6.1BRECOVERYQ 15$302.96+2.31%
- MIRMSELLMirum Pharmaceuticals, Inc.$5.1BRECOVERYQ 37$82.93+5.73%
- TLXSELLTelix Pharmaceuticals Limited$3.6BBEARQ -4$10.55+1.82%
- ACADSELLAcadia Pharmaceuticals Inc.$3.4BCRISISQ 18$19.95+1.02%
- DYNSELLDyne Therapeutics, Inc.$2.8BRECOVERYQ 3$15.20+1.65%
- SLNOSoleno Therapeutics, Inc.$2.8B$53.01
- RAREBUYUltragenyx Pharmaceutical Inc.$1.5BRECOVERYQ -6$15.22+1.24%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ADMA?
- LOPJLB’s latest quantitative signal on ADMA Biologics, Inc. (ADMA) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is ADMA in?
- ADMA Biologics, Inc. (ADMA) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does ADMA Biologics, Inc. (ADMA) do?
- ADMA Biologics, Inc. functions as a biopharmaceutical company specializing in the development, manufacturing, and commercialization of advanced biologic therapies derived from blood plasma. These specialized products are engineered to address immune system disorders and infectious diseases, catering to markets across the United States and internationally. Their current product portfolio include…